Tissue Culture Shared Resource

Home | Services & Fees | Educational Resources | Publications | Schedule

Publications

2003 2004 2005 2006 2007 2008 2009 2010 2011 2012

2011

Ariazi EA, Cunliffe HE, Lewis Wambi JS, Slifker MJ, Willis AL, Ramos P, Tapia C, Kim HR, Yerrum S, Sharma CG, Nicolas E, Balagurunathan Y, Ross EA, Jordan VC. Estrogen induces apoptosis in estrogen deprivationresistant breast cancer through stress responses as identified by global gene expression across time. Proc Natl Acad Sci U S A. 2011 Nov 22;108(47):18879- 86. Epub 2011 Oct 19. 22011582 3223472

Beauchamp EM, Ringer L, Bulut G, Sajwan KP, Hall MD, Lee YC, Peaceman D, Ozdemirli M, Rodriguez O, Macdonald TJ, Albanese C, Toretsky JA, Uren A. Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway. J Clin Invest. 2011 Jan;121(1):148-60. doi: 10.1172/JCI42874. Epub 2010 Dec 22. 21183792 3007144

Cheema AK, Timofeeva O, Varghese R, Dimtchev A, Shiekh K, Shulaev V, Suy S, Collins S, Ressom H, Jung M, Dritschilo A. Integrated analysis of ATM mediated gene and protein expression impacting cellular metabolism. J Proteome Res. 2011 May 6;10(5):2651-7. Epub 2011 Mar 7. 21322649

Chien CD, Kirilyuk A, Li JV, Zhang W, Lahusen T, Schmidt MO, Oh AS, Wellstein A, Riegel AT. Role of the nuclear receptor coactivator AIB1-Delta4 splice variant in the control of gene transcription. J Biol Chem. 2011 Jul 29;286(30):26813-27. Epub 2011 Jun 2. 21636853 3143642

Chou FP, Xu H, Lee MS, Chen YW, Richards OX, Swanson R, Olson ST, Johnson MD, Lin CY.
Matriptase is inhibited by extravascular antithrombin in epithelial cells but not in most carcinoma cells. Am J Physiol Cell Physiol. 2011 Nov;301(5):C1093-103. Epub 2011 Jul 27. 21795523 3213911

Cox DG, Simard J, Sinnett D, Hamdi Y, Soucy P, Ouimet M, Barjhoux L, Verny-Pierre C, McGuffog L, Healey S, Szabo C, Isaacs C, et al. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. Hum Mol Genet. 2011 Dec 1;20(23):4732-47. doi: 10.1093/hmg/ddr388. Epub 2011 Sep 2. 21890493

da Costa Prando E, Cavalli LR, Rainho CA. Evidence of epigenetic regulation of the tumor suppressor gene cluster flanking RASSF1 in breast cancer cell lines. Epigenetics. 2011 Dec;6(12):1413-24. 22139571 3256331

Deb TB, Zuo AH, Wang Y, Barndt RJ, Cheema AK, Sengupta S, Coticchia CM, Johnson MD. Pnck induces ligandindependent EGFR degradation by probable perturbation of the Hsp90 chaperone complex. Am J Physiol Cell Physiol. 2011 May;300(5):C1139- 54. Epub 2011 Feb 16.
21325639 3093937

Divekar SD, Storchan GB, Sperle K, Veselik DJ, Johnson E, Dakshanamurthy S, Lajiminmuhip YN, Nakles RE, Huang L, Martin MB. The role of calcium in the activation of estrogen receptor alpha. Cancer Res. 2011 Mar 1;71(5):1658- 68. Epub 2011 Jan 6.21212417 3057389

DiVito KA, Trabosh VA, Chen YS, Chen Y, Albanese C, Javelaud D, Mauviel A, Simbulan Rosenthal CM, Rosenthal DS. Smad7 restricts melanoma
invasion by restoring Ncadherin expression and establishing heterotypic cellcell interactions in vivo. Mol Cell Biol. 2011 Jul;31(13):2756-71. Epub 2011 May 2. 20738806 2975252

Erkizan HV, Scher LJ, Gamble SE, Barber-Rotenberg JS, Sajwan KP, Uren A, Toretsky JA. Novel peptide binds EWSFLI1 and reduces the oncogenic potential in Ewing tumors. Cell Cycle. 2011 Oct 1;10(19):3397-408. doi: 10.4161/cc.10.19.17 734. Epub 2011 Oct 1. 21926473 3233630

Grindrod S, Suy S, Fallen S, Eto M, Toretsky J, Brown ML. Effects of a fluorescent Myosin light chain phosphatase inhibitor on prostate cancer cells. Front Oncol. 2011;1:27. Epub 2011 Sep 20. 22655237 3356144

Hou L, Jiang B, Chen M, Ng J, Hurley CK. The characteristics of allelic polymorphism in killerimmunoglobulin-like receptor framework genes in African Americans.[Natural Killer cell reactivity] Immunogenetics. 2011 Sep;63(9):549-59. doi:10.1007/s00251-011-0536-6. Epub 2011 May 24. 21607693 3476846

Hu XD, Meng QH, Xu JY, Jiao Y, Ge CM, Jacob A, Wang P, Rosen EM, Fan S. BTG2 is an LXXLLdependent co-repressor for androgen receptor
transcriptional activity. Biochem Biophys
Res Commun. 2011 Jan 28;404(4):903-9. Epub 2010 Dec 21. 21172304

Hu ZZ, Kagan BL, Ariazi EA, Rosenthal DS, Zhang L, Li JV, Huang H, Wu C, Jordan VC, Riegel AT, Wellstein A. Proteomic analysis of pathways involved in estrogen-induced growth and apoptosis of breast cancer cells. PLoS One. 2011;6(6):e20410. Epub 2011 Jun 27. 21738574 3124472

Jung M, Timofeeva O, Cheema AK, Varghese R, Ressom H, Dritschilo A. Human fibroblasts for largescale omics" investigations of ATM gene function." Adv Exp Med Biol. 2011;720:181-90. 21901628

Kang HJ, Hong YB, Kim HJ, Rodriguez OC, Nath RG, Tilli EM, Albanese C, Chung FL, Kwon SH, Bae I. Detoxification: a novel function of BRCA1 in tumor suppression? Toxicol Sci. 2011 Jul;122(1):26-37. Epub 2011 Apr 19. 21507987 3143468

Kang HJ, Hong YB, Kim HJ, Yi YW, Nath RG, Chang YS, Cho HC, Bae I. A novel in vitro pancreatic carcinogenesis model. Toxicol Lett. 2011 Apr 10;202(1):15-22. Epub 2011 Jan 20. 21256203 3052416

Kim JS, Xu X, Li H, Solomon D, Lane WS, Jin T, Waldman T. Mechanistic analysis of a DNA damage-induced, PTEN-dependent size checkpoint in human cells. Mol Cell Biol. 2011 Jul;31(13):2756-71. doi:10.1128/MCB.01323 -10. Epub 2011 May 2 21536651 3133370

Krawczyk E, Suprynowicz FA, Hebert JD, Kamonjoh CM, Schlegel R. The human papillomavirus type 16 E5 oncoprotein translocates calpactin I to the perinuclear region. J Virol. 2011 Nov;85(21):10968-75. doi: 10.1128/JVI.00706- 11. Epub 2011 Aug 17. 21849434 3194938

Lewis-Wambi JS, Kim H, Curpan R, Grigg R, Sarker MA, Jordan VC. The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and downregulates estrogen receptor α and cyclin D1. Mol Pharmacol. 2011 Oct;80(4):610- 20. Epub 2011 Jul 7. 21737572 3187528

Li HF, Keeton A, Vitolo M, Maddox C, Rasmussen L, Hobrath J, White EL, Park BH, Piazza GA, Kim JS, Waldman T. A high-throughput screen with isogenic PTEN+/+ and PTEN- /- cells identifies CID1340132 as a novel compound that induces apoptosis in PTEN and PIK3CA mutant human cancer cells. J Biomol Screen. 2011 Apr;16(4):383-93 doi: 10.1177/108705711 0397357. Epub 2011 Feb 18. 21335596

Li X, Meng Q, Rosen EM, Fan S. UHRF1 confers radioresistance to human breast cancer cells. Int J Radiat Biol. 2011 Mar;87(3):263- 73. Epub 2010 Nov 10. 21067293

Lu C, Tilan JU, Everhart L, Czarnecka M, Soldin SJ, Mendu DR, Jeha D, Hanafy J, Lee CK, Sun J, Izycka-Swieszewska E, Toretsky JA, Kitlinska J. Dipeptidyl peptidases as survival factors in Ewing sarcoma family of tumors: implications for tumor biology and therapy. J Biol Chem. 2011 Aug 5;286(31):27494- 505. doi: 10.1074/jbc.M111.2 24089. Epub 2011 Jun 16. 21680731 3149342

Maximov P, Sengupta S, Lewis-Wambi JS, Kim HR, Curpan RF, Jordan VC. The Conformation of the Estrogen Receptor Directs Estrogen-Induced Apoptosis in Breast Cancer: A Hypothesis. Horm Mol Biol Clin Investig. 2011 Mar 1;5(1):27-34. 21660224 3109984

Mi L, Gan N, Chung FL. Isothiocyanates inhibit proteasome activity and proliferation of multiple myeloma cells. Carcinogenesis. 2011 Feb;32(2):216-23. doi: 10.1093/carcin/bgq242. Epub 2010 Nov 25. 21109604 3026846

Mi L, Hood BL, Stewart NA, Xiao Z, Govind S, Wang X, Conrads TP, Veenstra TD, Chung FL. Identification of potential protein targets of isothiocyanates by proteomics. Chem Res Toxicol. 2011 Oct 17;24(10):1735-43. doi: 10.1021/tx2002806. Epub 2011 Aug 26. 21838287 3493163

Mi L, Xiao Z, Veenstra TD, Chung FL. Proteomic identification of binding targets of isothiocyanates: A perspective on techniques. J Proteomics. 2011 Jun 10;74(7):1036- 44. doi: 10.1016/j.jprot.2011. 04.015. Epub 2011 Apr 30. 21555001 3107917

Mulligan AM, Couch FJ, Barrowdale D, Domchek SM, Eccles D, Nevanlinna H, et al. (Isaacs C) Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers
of BRCA1/2. Breast Cancer Res. 2011;13(6):R110. doi: 10.1186/bcr3052. Epub 2011 Nov 2. 22053997 3326552

Osorio A, Milne RL, Alonso R, Pita G, Peterlongo P, et al. (Isaac C) Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2. Br J Cancer. 2011 Apr 12;104(8):1356-

Pang D, Winters TA, Jung M, Purkayastha S, Cavalli LR, Chasovkikh S, Haddad BR, Dritschilo A. Radiation-generated short DNA fragments may perturb non-homologous end-joining and induce genomic instability J Radiat Res. 2011;52(3):309-19. 21628845

Pollock CB, Yin Y, Yuan H, Zeng X, King S, Li X, Kopelovich L, Albanese C, Glazer RI. PPARδ activation acts cooperatively with 3- phosphoinositide-dependent protein kinase-1 to enhance mammary tumorigenesis. PLoS One. 2011Jan 13;6(1):e16215. 21297860 3020974

Rahim S, Beauchamp EM, Kong Y, Brown ML, Toretsky JA, Uren A. YK-4-279 inhibits ERG and ETV1 mediated prostate cancer cell invasion. PLoS One. 2011 Apr 29;6(4):e19343. doi: 10.1371/journal.pon e.0019343. 21559405 3084826

Rahim S, Uren A. A real-time electrical impedance based technique to measure invasion of endothelial cell monolayer by cancer cells. J Vis Exp. 2011 Apr 1;(50). pii: 2792. doi: 10.3791/2792. 21490581

Rahimi M, Toth TA, Tang CK. CXCR4 suppression attenuates EGFRvIIImediated invasion and induces p38 MAPKdependent protein trafficking and degradation of EGFRvIII in breast cancer cells. Cancer Lett. 2011 Jul 1;306(1):43-51. Epub 2011 Mar 30. 21454012 3100082

Rebbeck TR, Mitra N, Domchek SM, Wan F, Friebel TM, Tran TV,; Epidemiological Study of BRCA1 and BRCA2 Mutation Carriers (EMBRACE), Isaacs C, et al. Modification of BRCA1- Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes. Cancer Res. 2011 Sep 1;71(17):5792-805. 21799032 3170727

Ricks-Santi LJ, Sucheston LE, Yang Y, Freudenheim JL, Isaacs CJ, Schwartz MD, Dumitrescu RG, Marian C, Nie J, Vito D, Edge SB, Shields PG Association of Rad51 polymorphism with DNA repair in BRCA1 mutation carriers and sporadic breast cancer risk. BMC Cancer. 2011 Jun 27;11:278. 21708019 3146938

Ringer L, Sirajuddin P, Heckler M, Ghosh A, Suprynowicz F, Yenugonda VM, Brown ML, Toretsky JA, Uren A, Lee Y, MacDonald TJ, Rodriguez O, Glazer RI, Schlegel R, Albanese C.
VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells. Cancer Biol Ther. 2011 Nov 1;12(9):818-26. Epub 2011 Nov 1. 21885916 3367670

Rotinen M, Villar J, Celay J, Serrano I, Notario V, Encío I. Transcriptional regulation of type 11 17β-hydroxysteroid dehydrogenase expression in prostate cancer cells. Mol Cell Endocrinol. 2011 Jun 6;339(1- 2):45-53. doi: 10.1016/j.mce.2011. 03.015. Epub 2011 Apr 28 21549806 3119890

Sahab ZJ, Hall MD, Me Sung Y, Dakshanamurthy S, Ji Y, Kumar D, Byers SW. Tumor suppressor RARRES1 interacts with cytoplasmic carboxypeptidase AGBL2 to regulate the α tubulin tyrosination cycle. Cancer Res. 2011 Feb 15;71(4):1219-28. doi: 10.1158/0008- 5472.CAN-10-2294. Epub 2011 Feb 8. 21303978 3062087

Sengupta A, Mateo-Lozano S, Tirado OM, Notario V. Auto-stimulatory action of secreted caveolin-1 on the proliferation of Ewing's sarcoma cells. Int J Oncol. 2011 May;38(5):1259-65. doi: 10.3892/ijo.2011.96 3. Epub 2011 Mar 3. 21373757 3335731

Solomon DA, Kim T, Diaz-Martinez LA, Fair J, Elkahloun AG, Harris BT, Toretsky JA, Rosenberg SA, Shukla N, Ladanyi M, Samuels Y, James CD, Yu H, Kim JS, Waldman T. Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science. 2011 Aug 19;333(6045):1039-43. doi: 10.1126/science.120 3619. 21852505 3374335

Spurdle AB, Marquart L, McGuffog L, Healey S, Sinilnikova O, Wan F, , et al. (Isaacs C) Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):1032-8 21393566 3089675

Su H, Sobrino Najul EJ, Toth TA, Ng CM, Lelievre SA, Fred M, Tang CK. Chemokine receptor CXCR4- mediated transformation of mammary epithelial cells by enhancing multiple RTKs expression and deregulation of the p53/MDM2 axis. Cancer Lett. 2011 Aug 28;307(2):132- 40. Epub 2011 May 6. 21530075

Tassi E, McDonnell K, Gibby KA, Tilan JU, Kim SE, Kodack DP, Schmidt MO, Sharif GM, Wilcox CS, Welch WJ, Gallicano GI, Johnson MD, Riegel AT, Wellstein A. Impact of fibroblast growth factor-binding protein-1 expression on angiogenesis and wound healing. Am J Pathol. 2011 Nov;179(5):2220-32. Epub 2011 Sep 21. 21945411 3204016

Upadhyay G, Yin Y, Yuan H, Li X, Derynck R, Glazer RI. Stem cell antigen-1 enhances tumorigenicity by disruption of growth differentiation factor- 10 (GDF10)-dependent TGFbeta signaling. Proc Natl Acad Sci U S A. 2011 May 10;108(19):7820-5. Epub 2011 Apr 25. 21518866 3093514

Vilboux T, Ciccone C, Blancato JK, Cox GF, Deshpande C, Introne WJ, Gahl WA, Smith AC, Huizing M. Molecular analysis of the Retinoic Acid Induced 1 gene (RAI1) in patients with suspected Smith-Magenis syndrome without the 17p11.2 deletion. PLoS One. 2011;6(8):e22861. Epub 2011 Aug 8. 21857958 3152558

Wang X, Di Pasqua AJ, Govind S, McCracken E, Hong C, Mi L, Mao Y, Wu JY, Tomita Y, Woodrick JC, Fine RL, Chung FL. Selective Depletion of Mutant p53 by Cancer Chemopreventive Isothiocyanates and Their Structure-Activity Relationships. J Med Chem. 2011 Feb 10;54(3):809- 16. Epub 2011 Jan 11. 21241062 3139710

Wang X, Govind S, Sajankila SP, Mi L, Roy R, Chung FL. Phenethyl isothiocyanate sensitizes human cervical cancer cells to apoptosis induced by cisplatin. Mol Nutr Food
Res. 2011. Oct;55(10):1572-81. doi: 10.1002/mnfr.20100 0560. Epub 2011 May 19. 21595016 3516716

Wang X, Di Pasqua AJ, Govind S, McCracken E, Hong C, Mi L, Mao Y, Wu JY, Tomita Y, Woodrick JC, Fine RL, Chung FL. Selective Depletion of Mutant p53 by Cancer Chemopreventive Isothiocyanates and Their Structure-Activity Relationships. J Med Chem. 2011 Feb 10;54(3):809- 16. Epub 2011 Jan 11. 21241062 3139710

Wang X, Govind S, Sajankila SP, Mi L, Roy R, Chung FL. Phenethyl isothiocyanate sensitizes human cervical cancer cells to apoptosis induced by cisplatin. Mol Nutr Food Res. 2011 Oct;55(10):1572-81. doi: 10.1002/mnfr.20100 0560. Epub 2011 May 19. 21595016 3516716

Yenugonda VM, Deb TB, Grindrod SC, Dakshanamurthy S, Yang Y, Paige M, Brown ML. Fluorescent cyclin-dependent kinase inhibitors block the proliferation of human breast cancer cells. Bioorg Med Chem. 2011 Apr 15;19(8):2714-25. Epub 2011 Mar 4. 21440449

Yon C, Viswanathan P, Rossignol JF, Korba B. Mutations in HCV nonstructural genes do not contribute to resistance to nitazoxanide in replicon containing cells. Antiviral Res. 2011 Sep;91(3):233-40. doi: 10.1016/j.antiviral.20 11.05.017. Epub 2011 Jun 14.
21703309 3159803

Zheng YL, Zhou X, Loffredo CA, Shields PG, Sun B. Telomere deficiencies on chromosomes 9p, 15p, 15q and Xp: potential biomarkers for breast cancer risk. Hum Mol Genet. 2011 Jan 15;20(2):378-86. Epub 2010 Oct 18. 20956286 3005901